Evolocumab for preventing major cardiovascular events in people aged 50 to 79 at high risk who have not had a myocardial infarction or stroke TS ID 11920

  • In development
  • GID-TA11482
  • Expected publication date: TBC

NIHRIO BN: 27407-Evolocumab-for-Cardiovascular-Events-V1.0-AUG2023-NON-CONF.pdf (nihr.ac.uk)